Cone-Specific Promoters for Gene Therapy of Achromatopsia and Other Retinal Diseases.

Abstract:

:Adeno-associated viral (AAV) vectors containing cone-specific promoters have rescued cone photoreceptor function in mouse and dog models of achromatopsia, but cone-specific promoters have not been optimized for use in primates. Using AAV vectors administered by subretinal injection, we evaluated a series of promoters based on the human L-opsin promoter, or a chimeric human cone transducin promoter, for their ability to drive gene expression of green fluorescent protein (GFP) in mice and nonhuman primates. Each of these promoters directed high-level GFP expression in mouse photoreceptors. In primates, subretinal injection of an AAV-GFP vector containing a 1.7-kb L-opsin promoter (PR1.7) achieved strong and specific GFP expression in all cone photoreceptors and was more efficient than a vector containing the 2.1-kb L-opsin promoter that was used in AAV vectors that rescued cone function in mouse and dog models of achromatopsia. A chimeric cone transducin promoter that directed strong GFP expression in mouse and dog cone photoreceptors was unable to drive GFP expression in primate cones. An AAV vector expressing a human CNGB3 gene driven by the PR1.7 promoter rescued cone function in the mouse model of achromatopsia. These results have informed the design of an AAV vector for treatment of patients with achromatopsia.

journal_name

Hum Gene Ther

journal_title

Human gene therapy

authors

Ye GJ,Budzynski E,Sonnentag P,Nork TM,Sheibani N,Gurel Z,Boye SL,Peterson JJ,Boye SE,Hauswirth WW,Chulay JD

doi

10.1089/hum.2015.130

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

72-82

issue

1

eissn

1043-0342

issn

1557-7422

journal_volume

27

pub_type

杂志文章
  • Lentiviral-mediated RNA interference.

    abstract::RNA interference (RNAi) is a form of posttranscriptional gene silencing mediated by short double-stranded RNA, known as small interfering RNA (siRNA). These siRNAs are capable of binding to a specific mRNA sequence and causing its degradation. The recent demonstration of a plasmid vector that directs siRNA synthesis i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303402320987888

    authors: Abbas-Terki T,Blanco-Bose W,Déglon N,Pralong W,Aebischer P

    更新日期:2002-12-10 00:00:00

  • Correction of pathological accumulation of glycosaminoglycans in central nervous system and peripheral tissues of MPSIIIA mice through systemic AAV9 gene transfer.

    abstract::Mucopolysaccharidosis type IIIA (MPSIIIA) is a rare lysosomal storage disorder caused by mutations in the sulfamidase gene. Accumulation of glycosaminoglycan (GAG) inside the lysosomes is associated with severe neurodegeneration as well as peripheral organ pathological changes leading to death of affected individuals ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2012.029

    authors: Ruzo A,Marcó S,García M,Villacampa P,Ribera A,Ayuso E,Maggioni L,Mingozzi F,Haurigot V,Bosch F

    更新日期:2012-12-01 00:00:00

  • Cancer gene therapy by direct tumor injections of a nonviral T7 vector encoding a thymidine kinase gene.

    abstract::Previously, we described a nonviral cytoplasmic gene therapy vector system based on the T7 autogene concept. This system has been shown to achieve rapid and high levels of gene expression in a variety of animal cells and tissues. To test the utility of the system in vivo tumor ablation, a T7 cancer gene therapy plasmi...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.5-729

    authors: Chen X,Li Y,Xiong K,Aizicovici S,Xie Y,Zhu Q,Sturtz F,Shulok J,Snodgrass R,Wagner TE,Platika D

    更新日期:1998-03-20 00:00:00

  • Retrovirus-mediated gene transfer into T cells: 95% transduction efficiency without further in vitro selection.

    abstract::This study was designed to retrovirally transduce T cells by a protocol that would be simple, short, cost effective, applicable for clinical use, and efficient enough to avoid further selection of transduced T cells. Because retrovirally mediated infection is depending on the cell cycle, we first optimized the conditi...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050015239

    authors: Movassagh M,Boyer O,Burland MC,Leclercq V,Klatzmann D,Lemoine FM

    更新日期:2000-05-20 00:00:00

  • Using a tropism-modified adenoviral vector to circumvent inhibitory factors in ascites fluid.

    abstract::Peritoneal compartmentalization of advanced stage ovarian cancer provides a rational scenario for gene therapy strategies. Several groups are exploring intraperitoneal administration of adenoviral (Ad) vectors for this purpose. We examined in vitro gene transfer in the presence of ascites fluid from ovarian cancer pat...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340050111313

    authors: Blackwell JL,Li H,Gomez-Navarro J,Dmitriev I,Krasnykh V,Richter CA,Shaw DR,Alvarez RD,Curiel DT,Strong TV

    更新日期:2000-08-10 00:00:00

  • Upregulation of Bag-1 by ex vivo gene transfer protects rat livers from ischemia/reperfusion injury.

    abstract::Bag-1 exerts powerful antiapoptotic effects by binding and stabilizing Bcl-2 and interacting with the tumor necrosis factor receptor type I-induced death signal. We examined the effects of overexpression of Bag-1 by ex vivo adenoviral gene transfer on cold (4 degrees C for 24 hr) ischemia/reperfusion (I/R) injury of r...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340260185120

    authors: Sawitzki B,Amersi F,Ritter T,Fisser M,Shen XD,Ke B,Busuttil R,Volk HD,Kupiec-Weglinski JW

    更新日期:2002-08-10 00:00:00

  • A novel parasite-derived suicide gene for cancer gene therapy with specificity for lung cancer cells.

    abstract::The enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT) expressed by the parasite Trypanosoma brucei (Tb) can convert allopurinol, a purine analogue, to corresponding nucleotides with greater efficiency than its human homologue. We have developed a retroviral system that expresses the parasitic enzyme and te...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340152528165

    authors: Trudeau C,Yuan S,Galipeau J,Benlimame N,Alaoui-Jamali MA,Batist G

    更新日期:2001-09-01 00:00:00

  • Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver.

    abstract::This multicenter phase I/II study evaluated the safety, pharmacokinetics, and antitumor effects of repeated doses of NV1020, a genetically engineered oncolytic herpes simplex virus, in patients with advanced metastatic colorectal cancer (mCRC). Patients with liver-dominant mCRC received four fixed NV1020 doses via wee...

    journal_title:Human gene therapy

    pub_type: 杂志文章,多中心研究

    doi:10.1089/hum.2010.020

    authors: Geevarghese SK,Geller DA,de Haan HA,Hörer M,Knoll AE,Mescheder A,Nemunaitis J,Reid TR,Sze DY,Tanabe KK,Tawfik H

    更新日期:2010-09-01 00:00:00

  • In vivo trafficking and targeted delivery of magnetically labeled stem cells.

    abstract::Targeted delivery of intravenously administered genetically altered cells or stem cells is still in an early stage of investigation. We developed a method of delivering iron oxide (ferumoxide)-labeled mesenchymal stem cells (MSCs) to a targeted area in an animal model by applying an external magnet. Rats with or witho...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303404322959506

    authors: Arbab AS,Jordan EK,Wilson LB,Yocum GT,Lewis BK,Frank JA

    更新日期:2004-04-01 00:00:00

  • Aerosol delivery of a beta-galactosidase adenoviral vector to the lungs of rodents.

    abstract::Aerosol delivery of adenoviral vectors is of particular interest in regard to gene therapy for cystic fibrosis (CF), with potential advantages of more uniform respiratory delivery, a less invasive approach, and ease of repetition. The AdHCMVsp1LacZ (AdLacZ) adenoviral vector was used to evaluate the feasibility of aer...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1995.6.8-985

    authors: Katkin JP,Gilbert BE,Langston C,French K,Beaudet AL

    更新日期:1995-08-01 00:00:00

  • Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.

    abstract::Abstract Our studies have shown that coinjection of conventional single-stranded adeno-associated virus 2 (ssAAV2) vectors carrying the enhanced green fluorescent protein (EGFP) gene with self-complementary (sc) AAV2-T cell protein tyrosine phosphatase (TC-PTP) and scAAV2-protein phosphatase-5 (PP5) vectors resulted i...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.100

    authors: Jayandharan GR,Zhong L,Sack BK,Rivers AE,Li M,Li B,Herzog RW,Srivastava A

    更新日期:2010-03-01 00:00:00

  • Mice with adenine phosphoribosyltransferase deficiency develop fatal 2,8-dihydroxyadenine lithiasis.

    abstract::Deficiencies in different steps of purine metabolism give rise to a number of human inherited disorders. Lesch-Nyhan syndrome is a severe neurological disorder, caused by a deficiency in the purine salvage enzyme hypoxanthine phosphoribosyltransferase (HPRT). HPRT-deficient mice have been generated, but have proved to...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.13-1491

    authors: Redhead NJ,Selfridge J,Wu CL,Melton DW

    更新日期:1996-08-20 00:00:00

  • Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.

    abstract::Unlike oncoretroviruses, lentiviral vectors can insert large genes and can target both dividing and nondividing cells; thus they hold unique promise as gene transfer agents. To enhance target range, the native lentiviral envelope glycoprotein is replaced (pseudotyped) with vesicular stomatitis virus G (VSVG), and the ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430340360464723

    authors: Kumar M,Bradow BP,Zimmerberg J

    更新日期:2003-01-01 00:00:00

  • Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson's disease cell model.

    abstract::Neurodegeneration in Parkinson's disease (PD) affects mainly dopaminergic neurons in the substantia nigra, where age-related, increasing percentages of cells lose detectable respiratory activity associated with depletion of intact mitochondrial DNA (mtDNA). Replenishment of mtDNA might improve neuronal bioenergetic fu...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.023

    authors: Keeney PM,Quigley CK,Dunham LD,Papageorge CM,Iyer S,Thomas RR,Schwarz KM,Trimmer PA,Khan SM,Portell FR,Bergquist KE,Bennett JP Jr

    更新日期:2009-08-01 00:00:00

  • Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia.

    abstract::Isolated methylmalonic acidemia (MMA), a group of autosomal recessive inborn errors of metabolism, is most commonly caused by complete (mut(0)) or partial (mut(-)) deficiency of the enzyme methylmalonyl-CoA mutase (MUT). The severe metabolic instability and increased mortality experienced by many affected individuals,...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2015.092

    authors: Harrington EA,Sloan JL,Manoli I,Chandler RJ,Schneider M,McGuire PJ,Calcedo R,Wilson JM,Venditti CP

    更新日期:2016-05-01 00:00:00

  • Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy.

    abstract::Retrovirus-mediated gene transfer is currently the most common method for the application of genetic therapy to cancer and many inherited and acquired disorders. Here we report the generation of an amphotropic producer cell line (CA2) that synthesizes viral particles carrying a bicistronic cassette in which the select...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.17-2165

    authors: Aran JM,Licht T,Gottesman MM,Pastan I

    更新日期:1996-11-10 00:00:00

  • Gene transfer into fetal baboon hematopoietic progenitor cells.

    abstract::We studied hematopoietic progenitors from fetal baboon blood, marrow, and liver at four time points (125, 140, 160, and 175 days) during the third trimester (gestation approximately 180 days) to determine if fetal baboons might be an appropriate model for in utero gene therapy of hematopoietic stem cells (HSCs). Cells...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950018742

    authors: Winkler A,Kiem HP,Shields LE,Sun QH,Andrews RG

    更新日期:1999-03-01 00:00:00

  • Retrovirus-mediated transfer of human alpha-galactosidase A gene to human CD34+ hematopoietic progenitor cells.

    abstract::Fabry disease, caused by a deficiency of lysosomal enzyme alpha-galactosidase A (alpha-gal A), is one of the inherited disorders potentially treatable by gene transfer to hematopoietic stem cells. In this study, a high-titer amphotropic retroviral producer cell line, MFG-alpha-gal A, was established. CD34+ cells from ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/10430349950016302

    authors: Takiyama N,Dunigan JT,Vallor MJ,Kase R,Sakuraba H,Barranger JA

    更新日期:1999-12-10 00:00:00

  • Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancer.

    abstract::The purpose of this study was to assess the therapeutic potential of injecting the gene for HLA-B7/beta2-microglobulin into the subcutaneous metastatic nodules of patients who are refractory to conventional treatments. The nine patients evaluated were divided into three groups and given escalating doses of DNA (20, 40...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.14-2031

    authors: Heo DS,Yoon SJ,Kim WS,Lee KH,Seol JG,Lee SG,Jung CW,Cho EK,Kim CW,Park MH,Sung MW,Kim KH,Bang YJ,Kim NK

    更新日期:1998-09-20 00:00:00

  • Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.

    abstract::Adenoviral vectors used in gene therapy are predominantly derived from adenovirus serotype 5 (Ad5), which infects a broad range of cells. Ad5 cell entry involves interactions with the coxsackie-adenovirus receptor (CAR) and integrins. To assess these receptors in vivo, we mutated amino acid residues in fiber and pento...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303403765255165

    authors: Smith TA,Idamakanti N,Rollence ML,Marshall-Neff J,Kim J,Mulgrew K,Nemerow GR,Kaleko M,Stevenson SC

    更新日期:2003-05-20 00:00:00

  • Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures.

    abstract::Rat myoblast primary cultures were tested as a model for proinsulin synthesis and processing and unregulated insulin delivery for insulin-dependent diabetes mellitus (IDDM) gene therapy. Three human proinsulin cDNA constructs containing genetically engineered furin endoprotease cleavage sites between the B-chain and C...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1996.7.1-71

    authors: Simonson GD,Groskreutz DJ,Gorman CM,MacDonald MJ

    更新日期:1996-01-01 00:00:00

  • Neonatal transfer of membrane-bound stem cell factor improves survival and heart function in aged mice after myocardial ischemia.

    abstract::Stem cell mobilization to injured tissue contributes to neovascularization, resulting in regeneration after myocardial infarction (MI). We previously showed that direct cardiac injection of a recombinant lentivirus (LV) that engineers expression of membrane-bound stem cell factor (mSCF) improves outcomes immediately a...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2012.063

    authors: Sun Z,Lee CJ,Mejia-Guerrero S,Zhang Y,Higuchi K,Li RK,Medin JA

    更新日期:2012-12-01 00:00:00

  • Helper-dependent adenoviral vectors containing modified fiber for improved transduction of developing and mature muscle cells.

    abstract::Adenoviruses (Ads) have shown great utility as vectors for the delivery of genes to mammalian cells, partly because of their ability to infect a wide range of different cell types independent of the replicative state of the cell. However, Ads do not transduce mature muscle efficiently because of low levels of the natu...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303404772679986

    authors: Bramson JL,Grinshtein N,Meulenbroek RA,Lunde J,Kottachchi D,Lorimer IA,Jasmin BJ,Parks RJ

    更新日期:2004-02-01 00:00:00

  • Therapeutic vaccination with an interleukin-2-interferon-gamma-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/II trial.

    abstract::Immunotherapy with whole cell cancer vaccines has been tested in various tumor types. This study investigated the safety profile and antitumor activity of an allogeneic prostate carcinoma cell line, LNCaP, expressing recombinant human interleukin-2 and human interferon-gamma. Thirty HLA-A*0201-matched patients with pr...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.101

    authors: Brill TH,Kübler HR,Pohla H,Buchner A,Fend F,Schuster T,van Randenborgh H,Paul R,Kummer T,Plank C,Eisele B,Breul J,Hartung R,Schendel DJ,Gansbacher B

    更新日期:2009-12-01 00:00:00

  • Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer.

    abstract::Artemis is a hairpin-opening endonuclease involved in nonhomologous end-joining and V(D)J recombination. Deficiency of Artemis results in radiation-sensitive severe combined immunodeficiency (SCID) characterized by complete absence of T and B cells due to an arrest at the receptor recombination stage. We have generate...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2009.162

    authors: Multhaup M,Karlen AD,Swanson DL,Wilber A,Somia NV,Cowan MJ,McIvor RS

    更新日期:2010-07-01 00:00:00

  • Soluble vascular endothelial growth factor receptor-1 improves therapeutic efficacy of suicide gene therapy in an angiogenesis-independent manner.

    abstract::Abstract Malignant gliomas (MGs) are highly vascularized, aggressive brain cancers carrying a dismal prognosis. Because of their high vascularity, anti-angiogenic therapy is a potential treatment option. Indeed, the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab has demonstrated promising results ...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2013.191

    authors: Samaranayake HD,Pikkarainen JT,Wirth T,Stedt H,Lesch HP,Dragneva G,Vuorio T,Määttä AM,Airenne K,Ylä-Herttuala S

    更新日期:2014-11-01 00:00:00

  • Direct comparison of steady-state marrow, primed marrow, and mobilized peripheral blood for transduction of hematopoietic stem cells in dogs.

    abstract::The optimal stem cell source for stem cell gene therapy has not been defined. Most gene transfer studies have used peripheral blood or marrow repopulating cells collected after administration of granulocyte colony-stimulating factor and stem cell factor (G-CSF/SCF). For clinical applications, however, growth factor ad...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303403322542329

    authors: Thomasson B,Peterson L,Thompson J,Goerner M,Kiem HP

    更新日期:2003-11-20 00:00:00

  • Highly efficient targeted transduction of undifferentiated human hematopoietic cells by adenoviral vectors displaying fiber knobs of subgroup B.

    abstract::Human hematopoietic stem cells (HSCs) are poorly transduced by vectors based on adenovirus serotype 5 (Ad5). This is primarily due to the paucity of the coxsackievirus-Ad receptor on these cells. In an attempt to change the tropism of Ad5, we constructed a series of chimeric E1-deleted Ad5 vectors in which the shaft a...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/104303401753204562

    authors: Knaän-Shanzer S,Van Der Velde I,Havenga MJ,Lemckert AA,De Vries AA,Valerio D

    更新日期:2001-11-01 00:00:00

  • Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.

    abstract::Replacement of the p53 tumor suppressor gene is a rational approach to the management of malignant gliomas because p53 is frequently mutated or inactivated in these cancers. Major weaknesses of this approach are that malignant gliomas are mixtures of cells with wild-type and mutant p53, and that tumor cells exhibiting...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.2005.16.685

    authors: Ito H,Kanzawa T,Miyoshi T,Hirohata S,Kyo S,Iwamaru A,Aoki H,Kondo Y,Kondo S

    更新日期:2005-06-01 00:00:00

  • Efficient transduction of hemopoietic CD34+ progenitors of human origin using an original retroviral vector derived from Fr-MuLV-FB29: in vitro assessment.

    abstract::A novel retroviral vector has been designed based on a Friend-murine leukemia virus (Fr-MuLV) FB29 strain. The latter has been selected according to characteristics of pathogenicity in mice where it induces a disease of the haemopoietic system affecting all lineages. Higher infectivity has also been demonstrated as co...

    journal_title:Human gene therapy

    pub_type: 杂志文章

    doi:10.1089/hum.1998.9.2-207

    authors: Cohen-Haguenauer O,Restrepo LM,Masset M,Bayer J,Dal Cortivo L,Marolleau JP,Benbunan M,Boiron M,Marty M

    更新日期:1998-01-20 00:00:00